Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GKOS NASDAQ:IRTC NASDAQ:PRCT NYSE:STVN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGKOSGlaukos$95.86-0.7%$95.62$77.10▼$163.71$5.50B0.78846,228 shs488,453 shsIRTCiRhythm Technologies$169.98-0.9%$150.26$55.92▼$172.59$5.51B1.41545,079 shs193,610 shsPRCTPROCEPT BioRobotics$40.17-0.4%$50.64$37.12▼$103.81$2.24B1.051.31 million shs769,202 shsSTVNStevanato Group€23.14-1.4%€24.22€17.12▼€28.00€7.10B0.55337,636 shs254,200 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGKOSGlaukos-0.71%+1.75%+1.96%+1.62%-29.20%IRTCiRhythm Technologies-0.87%+0.51%+21.34%+20.24%+147.93%PRCTPROCEPT BioRobotics-0.42%-2.57%-21.77%-31.45%-49.79%STVNStevanato Group-2.24%+2.75%-5.93%+4.94%+14.22%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGKOSGlaukos4.6745 of 5 stars4.44.00.04.42.71.70.6IRTCiRhythm Technologies1.2795 of 5 stars2.51.00.00.03.40.80.6PRCTPROCEPT BioRobotics3.485 of 5 stars4.41.00.00.04.22.50.6STVNStevanato Group3.0419 of 5 stars0.04.00.80.03.10.03.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGKOSGlaukos 2.79Moderate Buy$127.4232.92% UpsideIRTCiRhythm Technologies 3.00Buy$163.82-3.63% DownsidePRCTPROCEPT BioRobotics 2.78Moderate Buy$74.8886.40% UpsideSTVNStevanato Group 2.83Moderate BuyN/AN/ACurrent Analyst Ratings BreakdownLatest PRCT, STVN, IRTC, and GKOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$180.00 ➝ $193.008/21/2025IRTCiRhythm TechnologiesCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$167.00 ➝ $183.008/20/2025IRTCiRhythm TechnologiesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$200.008/15/2025GKOSGlaukosZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/7/2025PRCTPROCEPT BioRoboticsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$75.00 ➝ $58.008/7/2025PRCTPROCEPT BioRoboticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$80.00 ➝ $55.008/1/2025IRTCiRhythm TechnologiesWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy8/1/2025IRTCiRhythm TechnologiesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$145.00 ➝ $190.008/1/2025IRTCiRhythm TechnologiesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$139.00 ➝ $170.008/1/2025IRTCiRhythm TechnologiesWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $180.008/1/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$151.00 ➝ $180.00(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGKOSGlaukos$432.95M12.70N/AN/A$13.34 per share7.19IRTCiRhythm Technologies$591.84M9.23N/AN/A$3.23 per share52.63PRCTPROCEPT BioRobotics$274.95M8.13N/AN/A$6.93 per share5.80STVNStevanato Group€1.15B6.12€0.74 per share31.08€5.24 per share4.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGKOSGlaukos-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%11/3/2025 (Estimated)IRTCiRhythm Technologies-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)PRCTPROCEPT BioRobotics-$91.41M-$1.55N/AN/AN/A-30.60%-23.73%-17.34%10/27/2025 (Estimated)STVNStevanato Group€127.45M€0.5442.8539.902.2111.73%10.34%6.21%N/ALatest PRCT, STVN, IRTC, and GKOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025PRCTPROCEPT BioRobotics-$0.41-$0.35+$0.06-$0.35$75.67 million$79.18 million7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million7/30/2025Q2 2025GKOSGlaukos-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGKOSGlaukosN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ASTVNStevanato GroupN/AN/AN/AN/A1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGKOSGlaukos0.095.514.69IRTCiRhythm Technologies6.255.024.88PRCTPROCEPT BioRobotics0.139.217.86STVNStevanato Group0.251.791.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGKOSGlaukos99.04%IRTCiRhythm TechnologiesN/APRCTPROCEPT BioRobotics89.46%STVNStevanato GroupN/AInsider OwnershipCompanyInsider OwnershipGKOSGlaukos5.80%IRTCiRhythm Technologies1.10%PRCTPROCEPT BioRobotics6.60%STVNStevanato Group0.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGKOSGlaukos78057.35 million54.02 millionOptionableIRTCiRhythm Technologies2,00032.13 million31.78 millionOptionablePRCTPROCEPT BioRobotics43055.64 million51.96 millionOptionableSTVNStevanato Group4,650302.84 million300.72 millionOptionablePRCT, STVN, IRTC, and GKOS HeadlinesRecent News About These CompaniesTri Locum Partners LP Decreases Stake in Stevanato Group S.p.A. $STVNAugust 30 at 8:04 AM | marketbeat.comChamplain Investment Partners LLC Takes $15.74 Million Position in Stevanato Group S.p.A. $STVNAugust 30 at 6:39 AM | marketbeat.comRussell Investments Group Ltd. Purchases 91,663 Shares of Stevanato Group S.p.A. $STVNAugust 29 at 3:37 AM | marketbeat.comUSNA or STVN: Which Is the Better Value Stock Right Now?August 28 at 12:41 PM | zacks.com633,887 Shares in Stevanato Group S.p.A. $STVN Purchased by MetLife Investment Management LLCAugust 28 at 6:39 AM | marketbeat.comHere’s Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN)August 25, 2025 | insidermonkey.comT. Rowe Price Investment Management Inc. Has $76.47 Million Stock Position in Stevanato Group S.p.A. $STVNAugust 25, 2025 | marketbeat.comInvesco Ltd. Invests $19.07 Million in Stevanato Group S.p.A. $STVNAugust 24, 2025 | marketbeat.comStevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 21, 2025 | marketbeat.comStevanato Group S.p.A. $STVN Shares Acquired by LPL Financial LLCAugust 20, 2025 | marketbeat.comStevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of "Moderate Buy" from AnalystsAugust 20, 2025 | americanbankingnews.comDeutsche Bank AG Has $19.19 Million Holdings in Stevanato Group S.p.A. (NYSE:STVN)August 15, 2025 | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?August 12, 2025 | zacks.com93,709 Shares in Stevanato Group S.p.A. (NYSE:STVN) Bought by Zions Bancorporation National Association UTAugust 10, 2025 | marketbeat.comBrokers Set Expectations for Stevanato Group Q3 EarningsAugust 9, 2025 | marketbeat.comBlair William & Co. IL Purchases 137,625 Shares of Stevanato Group S.p.A. (NYSE:STVN)August 9, 2025 | marketbeat.comWilliam Blair Predicts Stronger Earnings for Stevanato GroupAugust 8, 2025 | marketbeat.comJackson Square Partners LLC Has $23.65 Million Holdings in Stevanato Group S.p.A. (NYSE:STVN)August 8, 2025 | marketbeat.comCenterBook Partners LP Raises Stock Position in Stevanato Group S.p.A. (NYSE:STVN)August 8, 2025 | marketbeat.comMutual of America Capital Management LLC Grows Holdings in Stevanato Group S.p.A. (NYSE:STVN)August 7, 2025 | marketbeat.comStevanato Group (NYSE:STVN) Stock Price Down 8.6% - Here's What HappenedAugust 6, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePRCT, STVN, IRTC, and GKOS Company DescriptionsGlaukos NYSE:GKOS$95.86 -0.70 (-0.73%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$95.80 -0.06 (-0.06%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.iRhythm Technologies NASDAQ:IRTC$169.98 -1.49 (-0.87%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$168.50 -1.48 (-0.87%) As of 08/29/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.PROCEPT BioRobotics NASDAQ:PRCT$40.17 -0.17 (-0.42%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$40.73 +0.56 (+1.39%) As of 08/29/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.Stevanato Group NYSE:STVN€23.14 -0.32 (-1.36%) As of 08/29/2025 03:58 PM EasternStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
